BioInvent International has reported encouraging interim Phase 2a results showing that combining its BI-1808 antibody with ...
After a year defined by disruption, denim’s strongest players emerged not by chance, but by design. From supply chain shifts ...
Andrew Hill Investment Advisors reports that client portfolios achieved double digit gains during 2025. Review our defensive ...